Latest On Celldex Therapeutics, Inc (CLDX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-18 18:33 EST | News | Celldex Therapeutics: Revolutionizing Cancer Care With Innovative Immunotherapies | N/A |  |
| 2023-05-04 23:29 EST | News | Celldex GAAP EPS of -$0.62, revenue of $1M | N/A | |
| 2023-03-02 14:39 EST | News | Celldex Therapeutics (CLDX) Presents At AAAAI Conference | N/A | |
| 2023-02-28 18:15 EST | News | Celldex GAAP EPS of -$0.56 beats by $0.03, revenue of $1.61M beats by $1.35M | N/A | |
| 2023-02-27 12:59 EST | News | Celldex gains 12% on Phase 1 data for urticaria candidate | N/A | |
| 2023-02-20 07:02 EST | News | Celldex: Long List Of Failures, High Valuation, But Good Data Recently | N/A | |
| 2022-12-02 20:42 EST | News | Celldex: Shares Continue To Rally On Barzolvolimab Hope (Technical Analysis) | N/A | |
| 2022-11-09 22:05 EST | News | Celldex GAAP EPS of -$0.57 beats by $0.01, revenue of $0.41M beats by $0.05M | N/A | |
| 2022-08-09 00:09 EST | News | Celldex Non-GAAP EPS of -$0.59 misses by $0.17, revenue of $0.16M misses by $0.24M | N/A | |
| 2022-07-22 13:36 EST | News | Celldex begins dosing in mid-stage study of barzolvolimab for skin disorder | N/A | |
| 2022-07-14 20:11 EST | News | Celldex: Barzolvolimab Plus Bispecific Antibodies Advancement | N/A | |
| 2022-07-01 20:44 EST | News | Celldex posts early-stage data to support dose-dependent effect of urticaria therapy | N/A | |
| 2022-05-06 00:47 EST | News | Celldex GAAP EPS of -$0.49 misses by $0.04, revenue of $0.17M misses by $0.39M | N/A | |
| 2022-03-01 04:31 EST | News | Celldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84M | N/A | |
| 2022-03-01 04:31 EST | News | Celldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-01 04:31 EST | News | Celldex Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-28 08:33 EST | News | Celldex Q4 2021 Earnings Preview | N/A | |
| 2022-02-17 13:49 EST | News | Celldex Therapeutics (CLDX) Investor Presentation - Slideshow | N/A | |
| 2022-02-01 06:48 EST | News | Celldex: Pipeline Of Drug Candidates Is Worth A Look | N/A | |
| 2021-11-12 18:41 EST | News | Celldex posts preclinical data from CDX-585 PD-1/ILT4 bispecific antibody program | N/A | |
| 2021-11-10 04:54 EST | News | Celldex EPS misses by $0.09, misses on revenue | N/A | |
| 2021-09-29 12:19 EST | News | Celldex's CDX-0159 improves quality of life and reduced disease impact in urticaria patients | N/A | |
| 2021-09-24 01:18 EST | News | Celldex Therapeutics: A Best Price-Positioned Biotech Stock As Seen By Market-Makers | N/A | |
| 2021-08-06 00:09 EST | News | Celldex EPS beats by $0.06, beats on revenue | N/A | |
| 2021-07-22 20:52 EST | News | Celldex rises with bullish call from Guggenheim; potential of lead asset cited | N/A | |
| 2021-07-21 00:15 EST | News | Celldex: Powerful Medicines To Yield Further Upsides | N/A | |
| 2021-07-21 00:14 EST | News | Celldex gains over a third on early-stage data for CDX-0159 in skin condition | N/A | |
| 2021-07-21 00:13 EST | News | Animal health ratings change at Guggenheim; Celldex up with positive views on trial data - today’s analyst action | N/A | |
| 2021-07-21 00:13 EST | News | Tempest Therapeutics, Xtant Medical leads healthcare gainers; Sigilon Therapeutics, TransMedics among major losers | N/A | |
| 2021-07-21 00:12 EST | News | Celldex Therapeutics proposes $175M capital raise | N/A | |
| 2021-07-21 00:12 EST | News | Celldex's Latest Data For Chronic Inducible Urticaria Drug Is Only The Beginning | N/A | |
| 2021-07-21 00:10 EST | News | Celldex Therapeutics raises $250M via equity offering | N/A | |
| 2021-05-07 05:42 EST | News | Celldex EPS misses by $0.08, misses on revenue | N/A | |
| 2021-03-30 03:43 EST | News | Celldex EPS misses by $0.18, beats on revenue | N/A | |
| 2021-03-29 08:13 EST | News | Celldex reports 80% complete response rate in CDX-0159 study in skin allergy | N/A | |
| 2021-03-02 07:24 EST | Analyst Rating | The Analyst Target Price has increased from $30.67 to $34.33. | Buy | |
| 2021-02-24 03:23 EST | Analyst Rating | The Analyst Target Price has increased from $26.33 to $30.67. | Buy | |
| 2021-02-22 18:38 EST | News | Celldex to expand development of CDX-0159 into prurigo nodularis | N/A | |
| 2021-01-17 17:51 EST | News | Celldex: New Monoclonal Therapeutic Line, 1Q21's CDX-0159's Initial Trial Data, And More | N/A | |
| 2020-12-13 03:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-09 15:50 EST | News | Dosing underway in Celldex's CDX-0159 study in skin allergy | N/A | |
| 2020-11-19 19:29 EST | Analyst Rating | The Analyst Target Price has increased from $23.5 to $26.33. | Buy | |
| 2020-11-10 03:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 03:34 EST | Analyst Rating | The Analyst Target Price has increased from $21.5 to $23.5. | Buy | |
| 2020-11-07 15:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 19:23 EST | Earnings Estimate | An EPS average of -$0.38 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-06 04:46 EST | News | Celldex EPS in-line, beats on revenue | N/A | |
| 2020-11-01 17:32 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-30 12:32 EST | Analyst Rating | The Analyst Target Price has increased from $17 to $21.5. | Buy | |
| 2020-10-14 09:13 EST | News | Dosing underway in Celldex Therapeutics' CDX-0159 early-stage skin disorder study | N/A | |
About Celldex Therapeutics, Inc (CLDX):
Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, which is being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in metastatic solid tumors and B cell lymphomas; CDX-3379, a monoclonal antibody designed to block the activity of ErbB3 that is in an early Phase II study in advanced head and neck squamous cell cancer in combination with Erbitux; CDX-0159, a Phase I monoclonal antibody that binds the KIT receptor and inhibits its activity; and CDX-527, a bispecific antibody that uses anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway. The company also holds exclusive rights to CDX-301 and CD40 ligand, which are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. Celldex Therapeutics, Inc. has research collaboration and license agreements with University of Southampton; Amgen Inc.; Yale University; and MedImmune, LLC. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
General
- Name Celldex Therapeutics, Inc
- Symbol CLDX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 127
- Last Split Factor1:15
- Last Split Date2019-02-11
- Fiscal Year EndDecember
- IPO Date2008-03-10
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.celldex.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 133.88
- Price/Book (Most Recent Quarter) 4.37
- Enterprise Value Revenue 186.73
- Enterprise Value EBITDA 0.01
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.38
- Operating Margin -1150%
- Return on Assets -17%
- Return on Equity -29%
- Revenue 4.52 million
- Earnings Per Share -$3.74
- Revenue Per Share $0.19
- Gross Profit -39099000
- Quarterly Earnings Growth 22.3%
View More
Highlights
- Market Capitalization 988.78 million
- EBITDA -51311000
- PE Ratio -14.63
- Analyst Target Price $34.33
- Book Value Per Share $5.81
View More
Share Statistics
- Shares Outstanding 39.57 million
- Shares Float 28.85 million
- % Held by Insiders 16%
- % Held by Institutions 82.07%
- Shares Short 2.87 million
- Shares Short Prior Month 3.44 million
- Short Ratio 4.18
- Short % of Float 7%
- Short % of Shares Outstanding 7%
View More
Technicals
- Beta 2.73
- 52 Week High $30.17
- 52 Week Low $1.51
- 50 Day Moving Average 25.2
- 200 Day Moving Average 18.9
View More
Dividends
- Dividend Date 2019-02-11
- ExDividend Date N/A
- Dividend Yield 0%
View More
Celldex Therapeutics, Inc (CLDX) Dividend Calendar:
CLDX's last dividend payment was made to shareholders on February 11, 2019.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Celldex Therapeutics, Inc (CLDX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-05 | $668000 | -$0.36 | -$0.36 | 0% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.50 | -$0.58 | 13.79% |
| 2020-03-31 | 2020-05-06 | $2.73 million | -$0.73 | -$0.70 | -4.29% |
| 2019-12-31 | 2020-03-26 | $887000 | -$0.64 | -$0.93 | 31.18% |
| 2019-09-30 | 2019-11-12 | $546000 | -$0.75 | -$0.84 | 10.71% |
| 2019-06-30 | 2019-08-07 | $715000 | -$0.84 | -$1.17 | 28.21% |
| 2019-03-31 | 2019-05-07 | $1.43 million | -$1.40 | -$1.14 | -22.81% |
| 2018-12-31 | 2019-03-07 | $1.76 million | -$0.81 | -$1.20 | 32.5% |
| 2018-09-30 | 2018-11-07 | $941000 | -$0.60 | -$2.25 | 73.33% |
| 2018-06-30 | 2018-08-08 | $2.76 million | -$1.65 | -$2.55 | 35.29% |
| 2018-03-31 | 2018-05-10 | $4.07 million | -$12.60 | -$3.03 | -315.84% |
| 2017-12-31 | 2018-03-07 | $3.46 million | -$0.45 | -$3.73 | 87.92% |
| 2017-09-30 | 2017-11-07 | $3.92 million | -$3.00 | -$3.98 | 24.53% |
| 2017-06-30 | 2017-08-08 | $3.83 million | -$3.45 | -$4.09 | 15.71% |
| 2017-03-31 | 2017-05-09 | $1.53 million | -$4.20 | -$4.28 | 1.75% |
| 2016-12-31 | 2017-03-14 | $1.87 million | -$4.50 | -$5.05 | 10.89% |
| 2016-09-30 | 2016-11-07 | $2.22 million | -$4.35 | -$4.97 | 12.42% |
| 2016-06-30 | 2016-08-08 | $1.39 million | -$4.80 | -$5.05 | 4.95% |
| 2016-03-31 | 2016-05-05 | $1.3 million | -$5.25 | -$5.24 | -0.29% |
| 2015-12-31 | 2016-02-23 | $1.79 million | -$4.95 | -$5.20 | 4.81% |
| 2015-09-30 | 2015-11-05 | $1.03 million | -$0.32 | -$0.35 | 8.57% |
| 2015-06-30 | 2015-08-10 | $2.18 million | -$0.33 | -$0.34 | 2.94% |
| 2015-03-31 | 2015-04-29 | $486000 | -$0.33 | -$0.36 | 8.33% |
| 2014-12-31 | 2015-02-24 | $1.48 million | -$0.36 | -$0.35 | -2.86% |
| 2014-09-30 | 2014-11-05 | $1.1 million | -$0.31 | -$0.33 | 6.06% |
| 2014-06-30 | 2014-08-06 | $592000 | -$4.80 | -$4.84 | 0.83% |
| 2014-03-31 | 2014-05-01 | $416000 | -$4.95 | -$3.94 | -25.63% |
| 2013-12-31 | 2014-03-03 | $620000 | -$4.05 | -$4.18 | 3.11% |
| 2013-09-30 | 2013-11-08 | $980000 | -$4.35 | -$3.66 | -18.85% |
| 2013-06-30 | 2013-08-06 | $97000 | -$3.60 | -$3.34 | -7.78% |
| 2013-03-31 | 2013-05-02 | $2.41 million | -$3.45 | -$3.30 | -4.55% |
| 2012-12-31 | 2013-03-07 | $3.65 million | -$4.05 | -$3.75 | -8% |
| 2012-09-30 | 2012-11-01 | $3.11 million | -$3.75 | -$3.62 | -3.59% |
| 2012-06-30 | 2012-08-10 | $2.01 million | -$3.45 | -$3.79 | 8.97% |
| 2012-03-31 | 2012-05-03 | $2.43 million | -$4.05 | -$3.57 | -13.45% |
| 2011-12-31 | 2012-03-07 | $2.43 million | -$4.35 | -$4.17 | -4.32% |
| 2011-09-30 | 2011-11-02 | $2.36 million | -$4.05 | -$3.84 | -5.47% |
| 2011-06-30 | 2011-08-03 | $1.95 million | -$4.05 | -$4.29 | 5.59% |
| 2011-03-31 | 2011-05-04 | $2.52 million | -$4.65 | -$4.54 | -2.42% |
| 2010-12-31 | 2011-03-03 | $2.13 million | -$3.60 | $3.15 | -214.29% |
| 2010-09-30 | 2010-11-02 | $2.41 million | -$4.35 | -$4.87 | 10.68% |
| 2010-06-30 | 2010-08-04 | $2.95 million | -$4.50 | -$3.95 | -13.92% |
| 2010-03-31 | 2010-05-04 | $3.71 million | -$3.15 | -$3.95 | 20.25% |
| 2009-12-31 | 2010-03-04 | $4.73 million | -$6.45 | -$4.30 | -50% |
| 2009-09-30 | 2009-11-04 | $4.03 million | -$6.75 | -$8.32 | 18.87% |
| 2009-06-30 | 2009-08-05 | $2.69 million | -$8.25 | -$7.10 | -16.2% |
| 2009-03-31 | 2009-05-05 | $3.73 million | -$7.35 | -$6.90 | -6.52% |
| 2008-12-31 | 2009-02-27 | $2.99 million | -$7.05 | -$8.10 | 12.96% |
| 2008-09-30 | 2008-11-05 | $2.36 million | -$7.50 | -$7.20 | -4.17% |
| 2008-06-30 | 2008-08-06 | $1.96 million | -$10.05 | -$8.40 | -19.64% |
| 2008-03-31 | 2008-05-19 | $147000 | -$32.85 | -$9.97 | -229.49% |
| 2007-12-31 | 2008-02-27 | $384000 | -$26.19 | ||
| 2007-09-30 | 2007-10-31 | $269000 | -$12.60 | -$12.60 | 0% |
| 2007-06-30 | 2007-08-02 | $609000 | -$12.60 | -$18.00 | 30% |
| 2007-03-31 | 2007-05-03 | $144000 | -$87.35 | ||
| 2006-12-31 | 2007-03-07 | $255000 | -$14.40 | -$14.40 | 0% |
| 2006-09-30 | 2006-11-01 | $199000 | -$14.40 | -$12.60 | -14.29% |
| 2006-06-30 | 2006-08-02 | $317000 | -$14.40 | -$12.60 | -14.29% |
| 2006-03-31 | 2006-05-09 | $128000 | -$7.20 | -$5.40 | -33.33% |
| 2005-12-31 | 2006-03-08 | $36000 | -$9.00 | -$10.80 | 16.67% |
| 2005-09-30 | 2005-10-27 | $23000 | -$10.80 | -$12.60 | 14.29% |
| 2005-06-30 | 2005-08-03 | $12000 | -$10.80 | -$6.30 | -71.43% |
| 2005-03-31 | 2005-05-05 | $N/A | -$12.60 | -$11.70 | -7.69% |
| 2004-12-31 | 2005-03-02 | -$9.00 | -$10.80 | 16.67% | |
| 2004-09-30 | 2004-10-20 | -$8.98 | |||
| 2004-06-30 | 2004-07-22 | -$9.00 | -$9.00 | 0% | |
| 2004-03-31 | 2004-04-21 | -$5.40 | -$9.00 | 40% | |
| 2003-12-31 | 2004-02-24 | -$9.00 | -$9.00 | 0% | |
| 2003-09-30 | 2003-10-22 | -$5.40 | -$10.80 | 50% | |
| 2003-06-30 | 2003-07-23 | -$9.48 | |||
| 2003-03-31 | 2003-04-30 | -$10.01 | |||
| 2002-12-31 | 2003-02-26 | -$10.80 | -$12.60 | 14.29% | |
| 2002-09-30 | 2002-10-23 | -$1.80 | -$16.20 | 88.89% | |
| 2002-06-30 | 2002-07-24 | -$16.20 | -$17.10 | 5.26% | |
| 2002-03-31 | 2002-04-24 | -$14.40 | -$18.00 | 20% | |
| 2001-12-31 | 2002-02-26 | -$19.80 | -$20.40 | 2.94% | |
| 2001-09-30 | 2001-10-25 | -$19.80 | -$23.40 | 15.38% | |
| 2001-06-30 | 2001-08-02 | -$18.00 | -$22.80 | 21.05% | |
| 2001-03-31 | 2001-04-25 | -$12.60 | -$16.20 | 22.22% | |
| 2000-12-31 | 2001-03-01 | -$14.40 | -$13.50 | -6.67% | |
| 2000-09-30 | 2000-10-25 | -$12.60 | -$12.60 | 0% | |
| 2000-06-30 | 2000-06-30 | -$9.79 | |||
| 2000-03-31 | 2000-04-27 | -$7.20 | -$10.80 | 33.33% | |
| 1996-12-31 | 1997-02-19 | -$16.20 | -$18.00 | 10% | |
| 1996-09-30 | 1996-11-06 | -$18.00 | -$18.00 | 0% | |
| 1996-06-30 | 1996-07-23 | -$39.60 | -$18.00 | -120% | |
| 1995-12-31 | 1996-02-27 | -$28.80 | -$25.20 | -14.29% | |
| 1995-09-30 | 1995-11-10 | -$32.40 | -$27.00 | -20% | |
| 1995-06-30 | 1995-08-11 | -$27.00 | -$25.20 | -7.14% | |
| 1995-03-31 | 1995-05-12 | -$25.20 | -$23.40 | -7.69% | |
| 1994-12-31 | 1995-02-15 | -$19.80 | -$35.10 | 43.59% | |
| 1994-09-30 | 1994-11-10 | -$23.40 | -$24.30 | 3.7% | |
| 1994-06-30 | 1994-08-02 | -$23.40 | -$25.20 | 7.14% | |
| 1994-03-31 | 1994-05-02 | -$19.80 | -$25.20 | 21.43% | |
| 1993-09-30 | 1993-10-29 | -$27.00 | -$21.60 | -25% | |
| 1993-03-31 | 1993-05-12 | -$23.40 | -$18.00 | -30% |
Celldex Therapeutics, Inc (CLDX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | 10.71 million | N/A | 11.7 million | N/A | 11.1 million |
| Income Before Tax | -14.22 million | N/A | -12.63 million | -10.45 million | -11.41 million |
| Selling General Administrative | 4.3 million | N/A | 3.67 million | 3.22 million | 3.4 million |
| Gross Profit | 668000 | N/A | N/A | -9.45 million | 546000 |
| Ebit | -14.22 million | N/A | -11.47 million | -12.67 million | -13.96 million |
| Operating Income | -14.34 million | N/A | -12.63 million | -12.67 million | -13.96 million |
| Income Tax Expense | N/A | -228000 | N/A | N/A | N/A |
| Total Revenue | 668000 | N/A | 2.73 million | 887000 | 546000 |
| Cost of Revenue | N/A | N/A | N/A | 10.34 million | N/A |
| Total Other Income Expense Net | N/A | N/A | 8000 | 2.22 million | 2.55 million |
| Net Income From Continuing Operations | -14.22 million | N/A | -12.63 million | -10.45 million | -11.41 million |
| Net Income Applicable to Common Shares | -14.22 million | -11.03 million | -12.63 million | -10.45 million | -11.41 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -42.36 million | N/A | 21.97 million | 3.33 million | 5.64 million |
| Change to Liabilities | 1.04 million | 599000 | N/A | 563000 | 714000 |
| Total Cash Flow from Investing Activities | -42.51 million | -108.53 million | N/A | 3.22 million | 5.52 million |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | 4.49 million | N/A | 1.64 million | 2.42 million | 2.46 million |
| Change to Operating Activities | N/A | -1.29 million | N/A | -2.95 million | -357000 |
| Change in Cash | -49.88 million | N/A | 11.49 million | -5.35 million | -3.16 million |
| Total Cash from Operating Activities | -11.86 million | -11.22 million | -12.11 million | -11 million | -11.14 million |
| Depreciation | 774000 | N/A | 1.17 million | 1.15 million | 1.21 million |
| Other Cash Flow from Investing Activities | 9000 | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | -161000 | 443000 |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 1.9 million | -1.43 million | N/A | 849000 | -1.74 million |
| Capital Expenditures | 160000 | N/A | 235000 | 105000 | 142000 |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 25.8 million | N/A | 28.8 million | 28.91 million | 30.46 million |
| Total Stockholder Equity | 229.98 million | N/A | 83.7 million | 94.03 million | 101.38 million |
| Other Current Liabilities | 3.63 million | N/A | 1.99 million | 2.03 million | 2.55 million |
| Total Assets | 255.77 million | N/A | 112.5 million | 122.93 million | 131.84 million |
| Common Stock | 40000 | 39000 | 83.7 million | 17000 | 16000 |
| Other Current Assets | 2.49 million | N/A | N/A | N/A | N/A |
| Retained Earnings | -1.05 billion | -1.04 billion | -1.03 billion | -1.01 billion | -1 billion |
| Other Liabilities | N/A | 10.4 million | 17.87 million | 15.55 million | 17.09 million |
| Other Assets | N/A | 41000 | N/A | 41000 | 129000 |
| Cash | 18.15 million | N/A | 22.72 million | 11.23 million | 16.59 million |
| Total Current Liabilities | 12.2 million | N/A | 10.93 million | 11.64 million | 11.89 million |
| Other Stockholder Equity | 2.61 million | 2.59 million | N/A | 2.62 million | 2.64 million |
| Property, Plant & Equipment | 3.81 million | 7.18 million | 4.12 million | 7.5 million | 7.92 million |
| Total Current Assets | 202.93 million | N/A | 55.92 million | 66.7 million | 75.1 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 184.79 million | 193.25 million | 31.23 million | 45.34 million | 52.69 million |
| Short Term Investments | 181.44 million | N/A | 31 million | 53.15 million | 56.33 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 8.58 million | N/A | 1.61 million | 1.17 million | 666000 |
Celldex Therapeutics, Inc (CLDX) Chart:
Celldex Therapeutics, Inc (CLDX) News:
Below you will find a list of latest news for Celldex Therapeutics, Inc (CLDX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Celldex Therapeutics, Inc (CLDX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 12.5 | 0 | CALL | 0 | 0 | 329.88 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 0 | CALL | 0 | 0 | 260.26 | TRUE | 0 | 0 |
| 2024-05-17 | 17.5 | 0 | CALL | 0 | 0 | 136.64 | TRUE | 0 | 0 |
| 2024-05-17 | 20 | 0 | CALL | 0 | 0 | 198.63 | TRUE | 0 | 0 |
| 2024-05-17 | 22.5 | 0 | CALL | 0 | 0 | 169.83 | TRUE | 0 | 0 |
| 2024-05-17 | 25 | 11.8 | CALL | 0 | 10 | 136.6 | TRUE | 0 | 0 |
| 2024-05-17 | 30 | 10.5 | CALL | 0 | 207 | 98.11 | TRUE | 0 | 0 |
| 2024-05-17 | 35 | 3 | CALL | 20 | 66 | 47.79 | TRUE | 3 | 0 |
| 2024-05-17 | 40 | 0.95 | CALL | 0 | 228 | 50.77 | FALSE | 0 | 0 |
| 2024-05-17 | 45 | 0.25 | CALL | 2 | 1053 | 55.51 | FALSE | 0.25 | 0 |
| 2024-05-17 | 50 | 0.15 | CALL | 0 | 1275 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 55 | 0.15 | CALL | 0 | 38 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 60 | 0.3 | CALL | 0 | 186 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 65 | 0.77 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 70 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 75 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 0.18 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 17.5 | 0.5 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 20 | 0.35 | PUT | 0 | 23 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 22.5 | 0.45 | PUT | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 25 | 0.45 | PUT | 0 | 166 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 30 | 0.25 | PUT | 0 | 286 | 58.06 | FALSE | 0 | 0 |
| 2024-05-17 | 35 | 1 | PUT | 20 | 80 | 52.81 | FALSE | 1 | 0 |
| 2024-05-17 | 40 | 2.9 | PUT | 0 | 85 | 60.98 | TRUE | 0 | 0 |
| 2024-05-17 | 45 | 1.8 | PUT | 0 | 601 | 84.39 | TRUE | 0 | 0 |
| 2024-05-17 | 50 | 6.3 | PUT | 0 | 4 | 110.12 | TRUE | 0 | 0 |
| 2024-05-17 | 55 | 0 | PUT | 0 | 0 | 137.42 | TRUE | 0 | 0 |
| 2024-05-17 | 60 | 0 | PUT | 0 | 0 | 144.42 | TRUE | 0 | 0 |
| 2024-05-17 | 65 | 0 | PUT | 0 | 0 | 157.28 | TRUE | 0 | 0 |
| 2024-05-17 | 70 | 0 | PUT | 0 | 0 | 175.85 | TRUE | 0 | 0 |
| 2024-05-17 | 75 | 0 | PUT | 0 | 0 | 260.66 | TRUE | 0 | 0 |
| 2024-06-21 | 20 | 0 | CALL | 0 | 0 | 122.17 | TRUE | 0 | 0 |
| 2024-06-21 | 22.5 | 0 | CALL | 0 | 0 | 110.71 | TRUE | 0 | 0 |
| 2024-06-21 | 25 | 0 | CALL | 0 | 0 | 93.1 | TRUE | 0 | 0 |
| 2024-06-21 | 30 | 0 | CALL | 0 | 0 | 52.07 | TRUE | 0 | 0 |
| 2024-06-21 | 35 | 0 | CALL | 0 | 0 | 61.79 | TRUE | 0 | 0 |
| 2024-06-21 | 40 | 2.9 | CALL | 0 | 268 | 49.28 | FALSE | 0 | 0 |
| 2024-06-21 | 45 | 0 | CALL | 0 | 0 | 49.05 | FALSE | 0 | 0 |
| 2024-06-21 | 50 | 0.75 | CALL | 0 | 12 | 50.35 | FALSE | 0 | 0 |
| 2024-06-21 | 55 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 20 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 22.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 25 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 30 | 0 | PUT | 0 | 0 | 55.34 | FALSE | 0 | 0 |
| 2024-06-21 | 35 | 0 | PUT | 0 | 0 | 50.42 | FALSE | 0 | 0 |
| 2024-06-21 | 40 | 0 | PUT | 0 | 0 | 46.72 | TRUE | 0 | 0 |
| 2024-06-21 | 45 | 0 | PUT | 0 | 0 | 59.14 | TRUE | 0 | 0 |
| 2024-06-21 | 50 | 0 | PUT | 0 | 0 | 74.81 | TRUE | 0 | 0 |
| 2024-06-21 | 55 | 0 | PUT | 0 | 0 | 95 | TRUE | 0 | 0 |
| 2024-08-16 | 17.5 | 0 | CALL | 0 | 0 | 110.47 | TRUE | 0 | 0 |
| 2024-08-16 | 20 | 0 | CALL | 0 | 0 | 90.66 | TRUE | 0 | 0 |
| 2024-08-16 | 22.5 | 0 | CALL | 0 | 0 | 88.49 | TRUE | 0 | 0 |
| 2024-08-16 | 25 | 17.8 | CALL | 0 | 3 | 76.79 | TRUE | 0 | 0 |
| 2024-08-16 | 30 | 0 | CALL | 0 | 10 | 56.29 | TRUE | 0 | 0 |
| 2024-08-16 | 35 | 0 | CALL | 0 | 10 | 49.62 | TRUE | 0 | 0 |
| 2024-08-16 | 40 | 3.6 | CALL | 0 | 104 | 57.54 | FALSE | 0 | 0 |
| 2024-08-16 | 45 | 2.15 | CALL | 0 | 180 | 47.76 | FALSE | 0 | 0 |
| 2024-08-16 | 50 | 1.87 | CALL | 0 | 26 | 46.42 | FALSE | 0 | 0 |
| 2024-08-16 | 55 | 1.35 | CALL | 0 | 36 | 48.33 | FALSE | 0 | 0 |
| 2024-08-16 | 60 | 0.35 | CALL | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 65 | 0.4 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 70 | 2.65 | CALL | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 75 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 17.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 20 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 22.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 25 | 0 | PUT | 0 | 0 | 54.57 | FALSE | 0 | 0 |
| 2024-08-16 | 30 | 1.1 | PUT | 0 | 1 | 51.68 | FALSE | 0 | 0 |
| 2024-08-16 | 35 | 2.85 | PUT | 0 | 76 | 49.9 | FALSE | 0 | 0 |
| 2024-08-16 | 40 | 5.4 | PUT | 0 | 33 | 48.38 | TRUE | 0 | 0 |
| 2024-08-16 | 45 | 7.4 | PUT | 0 | 16 | 43.16 | TRUE | 0 | 0 |
| 2024-08-16 | 50 | 0 | PUT | 0 | 0 | 51.39 | TRUE | 0 | 0 |
| 2024-08-16 | 55 | 0 | PUT | 0 | 0 | 68.45 | TRUE | 0 | 0 |
| 2024-08-16 | 60 | 0 | PUT | 0 | 0 | 80 | TRUE | 0 | 0 |
| 2024-08-16 | 65 | 0 | PUT | 0 | 0 | 70.13 | TRUE | 0 | 0 |
| 2024-08-16 | 70 | 0 | PUT | 0 | 0 | 115.05 | TRUE | 0 | 0 |
| 2024-08-16 | 75 | 0 | PUT | 0 | 0 | 125.84 | TRUE | 0 | 0 |
| 2024-09-20 | 20 | 0 | CALL | 0 | 0 | 91.38 | TRUE | 0 | 0 |
| 2024-09-20 | 22.5 | 0 | CALL | 0 | 0 | 73.79 | TRUE | 0 | 0 |
| 2024-09-20 | 25 | 0 | CALL | 0 | 0 | 74.1 | TRUE | 0 | 0 |
| 2024-09-20 | 30 | 0 | CALL | 0 | 0 | 53.58 | TRUE | 0 | 0 |
| 2024-09-20 | 35 | 0 | CALL | 0 | 0 | 52.04 | TRUE | 0 | 0 |
| 2024-09-20 | 40 | 4 | CALL | 0 | 2 | 50.55 | FALSE | 0 | 0 |
| 2024-09-20 | 45 | 0 | CALL | 0 | 0 | 58.73 | FALSE | 0 | 0 |
| 2024-09-20 | 50 | 2.1 | CALL | 0 | 1 | 48.83 | FALSE | 0 | 0 |
| 2024-09-20 | 55 | 0.85 | CALL | 0 | 1 | 48.76 | FALSE | 0 | 0 |
| 2024-09-20 | 20 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 22.5 | 0 | PUT | 0 | 0 | 57.29 | FALSE | 0 | 0 |
| 2024-09-20 | 25 | 0 | PUT | 0 | 0 | 54.97 | FALSE | 0 | 0 |
| 2024-09-20 | 30 | 0 | PUT | 0 | 0 | 53.71 | FALSE | 0 | 0 |
| 2024-09-20 | 35 | 0 | PUT | 0 | 0 | 49.54 | FALSE | 0 | 0 |
| 2024-09-20 | 40 | 0 | PUT | 0 | 0 | 49.46 | TRUE | 0 | 0 |
| 2024-09-20 | 45 | 0 | PUT | 0 | 0 | 44.3 | TRUE | 0 | 0 |
| 2024-09-20 | 50 | 0 | PUT | 0 | 0 | 56.82 | TRUE | 0 | 0 |
| 2024-09-20 | 55 | 0 | PUT | 0 | 0 | 65.25 | TRUE | 0 | 0 |
| 2024-11-15 | 20 | 0 | CALL | 0 | 0 | 79.53 | TRUE | 0 | 0 |
| 2024-11-15 | 22.5 | 0 | CALL | 0 | 0 | 75.03 | TRUE | 0 | 0 |
| 2024-11-15 | 25 | 0 | CALL | 0 | 0 | 57.96 | TRUE | 0 | 0 |
| 2024-11-15 | 30 | 11.8 | CALL | 0 | 16 | 59.67 | TRUE | 0 | 0 |
| 2024-11-15 | 35 | 11.3 | CALL | 0 | 10 | 57.25 | TRUE | 0 | 0 |
| 2024-11-15 | 40 | 5.5 | CALL | 0 | 11 | 55.43 | FALSE | 0 | 0 |
| 2024-11-15 | 45 | 5.1 | CALL | 0 | 4 | 54.2 | FALSE | 0 | 0 |
| 2024-11-15 | 50 | 4 | CALL | 0 | 1 | 54.08 | FALSE | 0 | 0 |
| 2024-11-15 | 55 | 4.3 | CALL | 0 | 1 | 54.04 | FALSE | 0 | 0 |
| 2024-11-15 | 60 | 0 | CALL | 0 | 0 | 53.62 | FALSE | 0 | 0 |
| 2024-11-15 | 65 | 0 | CALL | 0 | 0 | 52.86 | FALSE | 0 | 0 |
| 2024-11-15 | 70 | 0 | CALL | 0 | 0 | 52.07 | FALSE | 0 | 0 |
| 2024-11-15 | 20 | 0 | PUT | 0 | 0 | 64.42 | FALSE | 0 | 0 |
| 2024-11-15 | 22.5 | 0 | PUT | 0 | 0 | 62.67 | FALSE | 0 | 0 |
| 2024-11-15 | 25 | 0 | PUT | 0 | 0 | 61.52 | FALSE | 0 | 0 |
| 2024-11-15 | 30 | 2.25 | PUT | 0 | 4 | 56.4 | FALSE | 0 | 0 |
| 2024-11-15 | 35 | 0 | PUT | 0 | 0 | 55.81 | FALSE | 0 | 0 |
| 2024-11-15 | 40 | 0 | PUT | 0 | 0 | 54.3 | TRUE | 0 | 0 |
| 2024-11-15 | 45 | 0 | PUT | 0 | 0 | 53.35 | TRUE | 0 | 0 |
| 2024-11-15 | 50 | 0 | PUT | 0 | 0 | 52.41 | TRUE | 0 | 0 |
| 2024-11-15 | 55 | 0 | PUT | 0 | 0 | 52.05 | TRUE | 0 | 0 |
| 2024-11-15 | 60 | 0 | PUT | 0 | 0 | 61.1 | TRUE | 0 | 0 |
| 2024-11-15 | 65 | 0 | PUT | 0 | 0 | 65.07 | TRUE | 0 | 0 |
| 2024-11-15 | 70 | 0 | PUT | 0 | 0 | 70.03 | TRUE | 0 | 0 |
| 2025-01-17 | 12.5 | 0 | CALL | 0 | 0 | 99.49 | TRUE | 0 | 0 |
| 2025-01-17 | 15 | 23.9 | CALL | 0 | 4 | 92.07 | TRUE | 0 | 0 |
| 2025-01-17 | 18 | 20.8 | CALL | 0 | 0 | 76.05 | TRUE | 0 | 0 |
| 2025-01-17 | 20 | 12.1 | CALL | 0 | 2 | 75.6 | TRUE | 0 | 0 |
| 2025-01-17 | 23 | 10.1 | CALL | 0 | 2 | 66.39 | TRUE | 0 | 0 |
| 2025-01-17 | 25 | 23.41 | CALL | 0 | 6 | 66.25 | TRUE | 0 | 0 |
| 2025-01-17 | 28 | 21 | CALL | 0 | 110 | 59.74 | TRUE | 0 | 0 |
| 2025-01-17 | 30 | 10.9 | CALL | 0 | 299 | 61.39 | TRUE | 0 | 0 |
| 2025-01-17 | 32 | 9.67 | CALL | 0 | 0 | 58.98 | TRUE | 0 | 0 |
| 2025-01-17 | 35 | 11.27 | CALL | 0 | 100 | 58.31 | TRUE | 0 | 0 |
| 2025-01-17 | 37 | 7.67 | CALL | 0 | 89 | 58.25 | FALSE | 0 | 0 |
| 2025-01-17 | 40 | 6 | CALL | 10 | 30 | 55.92 | FALSE | 6 | 0 |
| 2025-01-17 | 42 | 8 | CALL | 0 | 0 | 56.35 | FALSE | 0 | 0 |
| 2025-01-17 | 45 | 5.15 | CALL | 0 | 24 | 55.96 | FALSE | 0 | 0 |
| 2025-01-17 | 50 | 4.25 | CALL | 0 | 66 | 54.96 | FALSE | 0 | 0 |
| 2025-01-17 | 55 | 4.65 | CALL | 0 | 34 | 52.19 | FALSE | 0 | 0 |
| 2025-01-17 | 60 | 2.78 | CALL | 0 | 188 | 52.86 | FALSE | 0 | 0 |
| 2025-01-17 | 65 | 5.2 | CALL | 0 | 111 | 56.68 | FALSE | 0 | 0 |
| 2025-01-17 | 70 | 1.1 | CALL | 0 | 242 | 53.53 | FALSE | 0 | 0 |
| 2025-01-17 | 75 | 1.25 | CALL | 0 | 2 | 53.7 | FALSE | 0 | 0 |
| 2025-01-17 | 12.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 15 | 1.75 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 18 | 0.6 | PUT | 0 | 40 | 60.89 | FALSE | 0 | 0 |
| 2025-01-17 | 20 | 1 | PUT | 0 | 2 | 77.2 | FALSE | 0 | 0 |
| 2025-01-17 | 23 | 0.9 | PUT | 0 | 92 | 70.53 | FALSE | 0 | 0 |
| 2025-01-17 | 25 | 1.6 | PUT | 0 | 287 | 69.37 | FALSE | 0 | 0 |
| 2025-01-17 | 28 | 3.7 | PUT | 0 | 50 | 60.46 | FALSE | 0 | 0 |
| 2025-01-17 | 30 | 3.3 | PUT | 0 | 449 | 62.88 | FALSE | 0 | 0 |
| 2025-01-17 | 32 | 6 | PUT | 0 | 1701 | 59.49 | FALSE | 0 | 0 |
| 2025-01-17 | 35 | 6.4 | PUT | 0 | 489 | 57.72 | FALSE | 0 | 0 |
| 2025-01-17 | 37 | 0 | PUT | 0 | 0 | 55.95 | TRUE | 0 | 0 |
| 2025-01-17 | 40 | 5.52 | PUT | 0 | 999 | 56.19 | TRUE | 0 | 0 |
| 2025-01-17 | 42 | 0 | PUT | 0 | 0 | 55.65 | TRUE | 0 | 0 |
| 2025-01-17 | 45 | 6.9 | PUT | 0 | 2 | 54.7 | TRUE | 0 | 0 |
| 2025-01-17 | 50 | 12.43 | PUT | 0 | 5 | 54.18 | TRUE | 0 | 0 |
| 2025-01-17 | 55 | 0 | PUT | 0 | 0 | 52.39 | TRUE | 0 | 0 |
| 2025-01-17 | 60 | 0 | PUT | 0 | 0 | 51.16 | TRUE | 0 | 0 |
| 2025-01-17 | 65 | 0 | PUT | 0 | 0 | 58.87 | TRUE | 0 | 0 |
| 2025-01-17 | 70 | 0 | PUT | 0 | 0 | 60.23 | TRUE | 0 | 0 |
| 2025-01-17 | 75 | 0 | PUT | 0 | 0 | 87.51 | TRUE | 0 | 0 |
Latest CLDX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 2 | $20.54 |
| Jun 13, 2022 7:59 PM EST | 61 | $20.52 |
| Jun 13, 2022 7:59 PM EST | 28 | $20.52 |
| Jun 13, 2022 7:59 PM EST | 1 | $20.51 |
| Jun 13, 2022 7:59 PM EST | 190 | $20.54 |
Celldex Therapeutics, Inc (CLDX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm |
| 2018-02-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000003877718000054/0000038777-18-000054-index.htm |
| 2018-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000021545718005851/0000215457-18-005851-index.htm |
| 2018-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000031506618001108/0000315066-18-001108-index.htm |
| 2018-05-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000031506618001910/0000315066-18-001910-index.htm |
| 2020-07-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000090266420002780/0000902664-20-002780-index.htm |
| 2020-06-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm |
| 2018-02-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000093247118003136/0000932471-18-003136-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000093247119004430/0000932471-19-004430-index.htm |
| 2020-10-22 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000093583620000571/0000935836-20-000571-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000103738920000083/0001037389-20-000083-index.htm |
| 2018-03-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/744218/000104746918001363/0001047469-18-001363-index.htm |
| 2018-04-19 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/744218/000104746918002964/0001047469-18-002964-index.htm |
| 2018-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/744218/000104746918003326/0001047469-18-003326-index.htm |
| 2019-03-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/744218/000104746919000992/0001047469-19-000992-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/744218/000104746919002607/0001047469-19-002607-index.htm |
| 2019-12-06 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/744218/000104746919006714/0001047469-19-006714-index.htm |
| 2020-03-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/744218/000104746920001809/0001047469-20-001809-index.htm |
| 2020-04-28 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/744218/000104746920002644/0001047469-20-002644-index.htm |
| 2020-06-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/744218/000104746920003564/0001047469-20-003564-index.htm |
| 2020-06-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/744218/000104746920003601/0001047469-20-003601-index.htm |
| 2020-06-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/744218/000104746920003602/0001047469-20-003602-index.htm |
| 2020-06-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/744218/000104746920003646/0001047469-20-003646-index.htm |
| 2018-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465918026170/0001104659-18-026170-index.htm |
| 2018-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/744218/000110465918031972/0001104659-18-031972-index.htm |
| 2018-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465918037447/0001104659-18-037447-index.htm |
| 2018-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465918040165/0001104659-18-040165-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/744218/000110465918050496/0001104659-18-050496-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/744218/000110465918066648/0001104659-18-066648-index.htm |
| 2018-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465918070024/0001104659-18-070024-index.htm |
| 2018-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465918072097/0001104659-18-072097-index.htm |
| 2019-02-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465919006667/0001104659-19-006667-index.htm |
| 2019-05-07 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/744218/000110465919027504/0001104659-19-027504-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/744218/000110465919027513/0001104659-19-027513-index.htm |
| 2019-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465919036671/0001104659-19-036671-index.htm |
| 2019-06-21 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/744218/000110465919036997/0001104659-19-036997-index.htm |
| 2019-06-21 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/744218/000110465919037010/0001104659-19-037010-index.htm |
| 2019-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465919037195/0001104659-19-037195-index.htm |
| 2019-07-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000110465919039565/0001104659-19-039565-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/744218/000110465919044531/0001104659-19-044531-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/744218/000110465919062181/0001104659-19-062181-index.htm |
| 2020-03-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/744218/000110465920039253/0001104659-20-039253-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/744218/000110465920057436/0001104659-20-057436-index.htm |
| 2020-06-12 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/744218/000110465920072503/0001104659-20-072503-index.htm |
| 2020-06-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/744218/000110465920072779/0001104659-20-072779-index.htm |
| 2020-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465920072934/0001104659-20-072934-index.htm |
| 2020-06-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465920073386/0001104659-20-073386-index.htm |
| 2020-06-15 | S-3MEF | Registration adding securities to prior Form S-3 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/744218/000110465920073505/0001104659-20-073505-index.htm |
| 2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465920073843/0001104659-20-073843-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465920074646/0001104659-20-074646-index.htm |
| 2020-06-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/744218/000110465920077437/0001104659-20-077437-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/744218/000110465920091459/0001104659-20-091459-index.htm |
| 2020-08-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465920096505/0001104659-20-096505-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/744218/000110465920121786/0001104659-20-121786-index.htm |
| 2020-11-06 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/744218/000110465920122483/0001104659-20-122483-index.htm |
| 2020-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000110465920122521/0001104659-20-122521-index.htm |
| 2018-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184318001754/0001171843-18-001754-index.htm |
| 2018-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184318002723/0001171843-18-002723-index.htm |
| 2018-05-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184318003787/0001171843-18-003787-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184318005867/0001171843-18-005867-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184318007706/0001171843-18-007706-index.htm |
| 2019-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184319001578/0001171843-19-001578-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184319003062/0001171843-19-003062-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184319005251/0001171843-19-005251-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184319007429/0001171843-19-007429-index.htm |
| 2020-03-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184320002037/0001171843-20-002037-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184320003372/0001171843-20-003372-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184320005651/0001171843-20-005651-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/744218/000117184320007664/0001171843-20-007664-index.htm |
| 2018-03-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018003192/0001179110-18-003192-index.htm |
| 2018-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018005108/0001179110-18-005108-index.htm |
| 2018-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018006035/0001179110-18-006035-index.htm |
| 2018-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018007858/0001179110-18-007858-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008556/0001179110-18-008556-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008557/0001179110-18-008557-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008558/0001179110-18-008558-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008559/0001179110-18-008559-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008560/0001179110-18-008560-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008561/0001179110-18-008561-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008562/0001179110-18-008562-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008563/0001179110-18-008563-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008564/0001179110-18-008564-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008565/0001179110-18-008565-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008566/0001179110-18-008566-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008567/0001179110-18-008567-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008568/0001179110-18-008568-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008569/0001179110-18-008569-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008570/0001179110-18-008570-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm |
| 2018-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018009240/0001179110-18-009240-index.htm |
| 2018-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018010087/0001179110-18-010087-index.htm |
| 2018-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm |
| 2018-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018011797/0001179110-18-011797-index.htm |
| 2018-11-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018012450/0001179110-18-012450-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911018013378/0001179110-18-013378-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007967/0001179110-19-007967-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007968/0001179110-19-007968-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007969/0001179110-19-007969-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007970/0001179110-19-007970-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007971/0001179110-19-007971-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007972/0001179110-19-007972-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007973/0001179110-19-007973-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007974/0001179110-19-007974-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007975/0001179110-19-007975-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007976/0001179110-19-007976-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007977/0001179110-19-007977-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007978/0001179110-19-007978-index.htm |
| 2019-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019007979/0001179110-19-007979-index.htm |
| 2019-07-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911019008540/0001179110-19-008540-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm |
| 2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007585/0001179110-20-007585-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007586/0001179110-20-007586-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007587/0001179110-20-007587-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007588/0001179110-20-007588-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007589/0001179110-20-007589-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007590/0001179110-20-007590-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007591/0001179110-20-007591-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007592/0001179110-20-007592-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007593/0001179110-20-007593-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007594/0001179110-20-007594-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007595/0001179110-20-007595-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007596/0001179110-20-007596-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007597/0001179110-20-007597-index.htm |
| 2020-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000117911020007598/0001179110-20-007598-index.htm |
| 2018-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/744218/000118248918000319/0001182489-18-000319-index.htm |
| 2018-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000119312518041541/0001193125-18-041541-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000119312519039738/0001193125-19-039738-index.htm |
| 2020-06-18 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000119312520171962/0001193125-20-171962-index.htm |
| 2020-06-19 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/744218/000149315220011453/0001493152-20-011453-index.htm |
| 2020-06-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/744218/999999999520001412/9999999995-20-001412-index.htm |
| 2018-04-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/744218/999999999718005092/9999999997-18-005092-index.htm |
Celldex Therapeutics, Inc (CLDX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Celldex Therapeutics, Inc (CLDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 16%Institutional Ownership: 8207%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-06-09 | Margo Heath-Chiozzi | SVP of Regulatory Affairs | Buy | 1,000.00 | 3.01 | 3,005.00 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm |
| 2020-06-09 | Samuel Bates Martin | SVP and CFO | Buy | 9,750.00 | 3.05 | 29,737.50 | 10,735.00 | https://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm |
| 2020-06-09 | JAMES J MARINO | Director | Buy | 8,305.00 | 3.00 | 24,915.00 | 12,704.00 | https://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm |
| 2020-06-10 | Sarah Cavanaugh | SVP of Corp Affairs & Admin. | Buy | 1,050.00 | 4.83 | 5,071.50 | 1,367.00 | https://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm |
| 2020-06-09 | Anthony S Marucci | President & CEO | Buy | 15,000.00 | 3.06 | 45,900.00 | 19,438.00 | https://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm |
| 2020-06-11 | Diane C. Young | SVP, Chief Medical Officer | Buy | 2,115.00 | 4.73 | 10,003.95 | 2,115.00 | https://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm |
| 2018-06-15 | TIBOR KELER | Executive VP & CSO | Buy | 16,500.00 | 0.59 | 9,782.85 | 35,368.00 | https://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm |
| 2018-08-24 | JAMES J MARINO | Director | Buy | 40,000.00 | 0.48 | 19,200.00 | 65,997.00 | https://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm |
| 2020-06-09 | TIBOR KELER | Executive VP & CSO | Buy | 5,000.00 | 2.99 | 14,954.00 | 7,357.00 | https://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm |